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THE USE OF METHOXSALEN IN SUN TANNING
OTTO C. STEGMATER, M.D.
Davenport, Iowa
This study concerns 30 volunteers with normal
skin who were under methoxsalen therapy before
receiving solar radiation as a protective measure
against sunburn. Observations of skin responses
to Black Light radiation comprises a corollary
portion of the study.
The occurrence of an unusual bronzing of
normal skin, while under psoralen therapy for
vitiligo, aroused Fitzpatrick's curiosity (1).
Many other vitiligo patients under his care
noted that the normal skin and the depigmcnted
skin could tolerate more sunlight without
burning. Following these two observations the
"Sun Tan Pill Era" was initiated and further
exploration of this fascinating subject was begun(2, 3). This was the summer of 1953. Upon
receipt of this information, the present study
began.
METHOD
Since the summer of 1954, 30 persons with
normal skin have been observed for this increase
in pigmentation and decrease in burning (1)
after ingestion of mcthoxsalen and exposure to
solar radiation. Twenty-five of these were either
blonds or red heads with fair skin which sun-
burned readily. Many of these had never enjoyed
the summer months because of the severe burning
and blistering which results from short exposures.
Five other volunteers were placed on the psoralen
to augment the normally acquired tan and to do
so in a shorter period of time. The exposures to
sunlight occurred while the volunteers were at
work, on vacation, and particularly while around
water during the noon hours of the summer
months. No controlled studies with measured
periods of sunlight nor with double blind placebos
were attempted. The dosage of medication varied
but most patients took 20 mgm., one to three
hours before exposure to radiation. Since the
most efficient method of administration was not
known initially, some volunteers took 10 mgm.
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three times a day after meals. In others, the
dosage was as low as 10 mgm. a day. All of those
cooperating have been under medication for at
least three days a week for one summer, or daily
for three weeks in Florida or Mexico in the winter.
Two patients have been on medication each
summer for the past four years. All of the volun-
teers were over 21 years of age except three. The
results of liver function studies and blood counts
before and after the experimentation were
normal.
RE5ULT5
Fifteen of the 25 persons bad excellent results
in preventing severe sunburn following exposure
to sunlight. Twelve of these fifteen could enjoy
summer sports for the first time in their lives.
Eight felt that the protective action had been
helpful but these persons were not as enthusiastic
as the other fifteen. Two of the volunteers stated
the capsules were of no benefit in preventing
sunburn. The best results were noted when
methoxsalen was taken in early summer or when
the volunteers were on winter vacations in the
southern latitudes. Eighteen of the 25 appeared
to be darker in color than on previous occasions
without psoralens. This was substantiated by the
volunteers' friends and relatives. While the
double blind placebo tests were not performed,
both of the above results (increased tanning and
toleration) were diminished when the persons
were off of the medication.
The five volunteers, whose skin bad always
tanned well, noted increased tanning and in less
time than ever before (4). In three of five the skin
assumed an intense chocolate brown color, par-
ticularly after vacation trips to Florida.
Three patients with atopic eczema had been
on methoxsalen therapy last summer. They were
placed on this therapy because the flexurcs of
the arms did not tan as well as the remainder of
the skin. All three of them showed rcpigmentation
of these areas while on psoralen therapy. How-
ever, this winter the pigmentation began to
disappear from these areas. Three patients with
psoriasis were also under medication with sunS
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light and psoralen therapy last summer after
their disease had cleared under the Goeckerman
regime. These three patients have remained free
of this disease during the past winter. No definite
conclusions can he drawn as to the relative
effectiveness of the psoralens in psoriasis.
UNUSUAL INCIDENTS
One of the 25 volunteers, a 36 year old male,
under medication with methoxsalen therapy,
spent two weeks in the mountains in Colorado.
Two months later a basal cell carcinoma of the
skin developed. This man had no previous history
of skin cancers, nor of previous arsenic adminis-
tration or x-ray therapy to the skin of the face.
A fifty-one year old woman lost muscular
coordination each time following methoxsalen
therapy and sunlight exposure. Blood studies and
liver function tests did not reveal anything
abnormal.
Two of the 25 volunteers were children, ages
four and five. During the second week of therapy
a severe eheilitis and marked edema of the feet
forced cessation of therapy.
BLACK LIGHT AND METHOX5ALEN
While the action spectrum of methoxsalen is
not definitely known, Fitzpatrick stated that it
potentiates the action of ultra-violet at 2900
A and also at wave lengths longer than 3100 A
which pass through window glass (1). Elliott has
demonstrated that following ingestion of methox-
salen and exposure to the Wood's light, which
emits nothing shorter than 3400 A, erythema and
pigmentation results (5). Since the fluorescent
black light lamp* emits most of its energy in the
near ultraviolet, that is, greater than 3200 A, it
would appear to be an excellent source of light
to use in conjunction with psoralens for further
study and evaluation of the skin responses.
(Fig. 1) These lamps emit radiation over a large
surface, in contrast to the mercury vapor Wood's
light. They are inexpensive—less than $2.00 per
lamp—and no elaborate expensive equipment is
needed to activate the lights. Therefore, they
were selected for experimental usage.
METHOD
Four by four inch sites on the back of a 20
year old male with good tanning ability were
* General Electric BL lamp. I wish to acknowl-
edge information received from E. W. Schoenherr
of the General Electric Lamp Division, Rock
Island, Illinois.
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FIG. 1. Spectral energy distribution of black
light fluorescent lamp. (General Electric BL
lamp).
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used as test sites. A commercial fluorescent
fixture, with baked enamel reflecting surface,
housing three 48 inch, 40 watt black light fluores-
cent lamps was used as the source of irradiation.
The distance from skin to the lamps was six
inches. (Fig. 2) The right side was exposed to 30
minutes daily for 7 days (Area *' 1). The left
side (Area #2) was exposed to the same amount,
but preceded by the administration of 50 mgm.
of methoxsalen daily. A biopsy specimen was
taken from this site 11 days after the initial
exposure. A third site (Area #3) was exposed
similarly to Area #2 except that the radiation
was filtered through window glass. The areas
exposed were being irradiated with approximately
4286 footlamberts.
RESULTS
Area #1. No erythema developed. A faint
pigmentation was noted within two hours after
the start of the exposure and this darkening was
only intensified after seven days of irradiation.
Area #2. Erythema developed in approxi-
mately 17 hours after the initial exposure. Pig-
mentation was noted at the end of the first
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FIG. 2. Method of experimentation.
Figure 3
FIG. 3. Photograph of Area fl. This was taken nine days after the beginning of
the experiment.
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and since these rays were probably filtered out
by the window glass, it would appear that
methoxsalen taken orally potentiates the effects
of near ultraviolet radiation (above 3200 A) on
the skin. This technic should prove to be an inex-
pensive artificial source of radiation to produce
erythema and pigmentation and it should be
applied in the treatment of vitiligo, psoriasis
and other dermatological diseases on an experi-
mental basis.
SUMMARY
FIG. 4. Photograph of Area #2 and Area #3 in
a 38 year old test subject. Area #2—11 days after
beginning of exposure (BL lamp plus 8-MOP).
Area #3—3 days after beginning of exposure (BL
lamp filtered through window glass plus 8-MOP).
exposure, i.e., thirty minutes after the start of the
exposure. It was impossible to determine exactly
when the dark bronze color first appeared, but
it was apparent at the end of 48 hours. Photo-
graphs taken at the end of nine days after the
onset revealed the intense pigmentation which
resulted. (Fig. 3). Tenderness and some burning
began after four days of exposure and had disap-
peared by the ninth day.
Area #3. Erythema developed similarly as
area #2, but was not an intense. Pigmentation
had not appeared by the third day when the
experiment had to be interrupted.
A skin biopsy specimen of area #2, taken on
the eleventh day, revealed a definite thickening of
the corneal layer and the formation of a beginning
stratum lucidum (6). A mild perivaseular infil-
trate was present in the upper eutis.
This entire procedure was duplicated on the
skin of a 38 year old woman with very fair skin.
The results were identical except that resultant
pigmentation was not as intense. (Fig. 4) No
specimen for biopsy was taken.
COMMENTS
Since very small amounts of middle ultraviolet
light (2900—3200 A) are emitted by this lamp
1. In 25 normal persons, methoxsalen taken
orally before exposure to sunlight provided
protection against sunburn in 23 and produced
increased pigmentation in 18.
2. It greatly potentiated tanning in five out of
five volunteers studied.
3. Methoxsalen appears to increase the effects
of black light fluorescent radiation on the skin
when taken prior to exposure. It appears to
intensify the near ultraviolet spectra (above
3200 A).
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